Editor's Note

Recalibrating India’s Pharma Realm from Volume-driven to Value-driven

Transitioning from a mere "volume-driven" generics market to a "value-driven" innovation hub, MedTech startups are revolutionizing India's pharma sector in 2026. This evolution is being triggered by the integra­tion of advanced technologies such as AI, deep tech, and advanced diagnostics into pharmaceutical development and distribution. With this, this niche segment is projected to reach approximately USD 50 billion by 2030.

The sector is prioritizing affordable, indigenous, and AI-driven innovations to address access challenges, with strong support...  >>More